Robert Hagemann, Director at ZIMMER BIOMET HOLDINGS, INC. (ZBH), bought 2,000 shares at $119.83 ($240K) on 2019-02-05, disclosed to the SEC on 2019-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GPK | BUY | 2019-02-28 | $184K | — | Filing → |
| R | BUY | 2015-02-10 | $216K | — | Filing → |
| GPK | BUY | 2015-02-10 | $180K | — | Filing → |